A Case of Concurrent Miller-Dieker Syndrome (17p13.3 Deletion) and 22q11.2 Deletion Syndrome

Abstract

Features of Miller-Dieker syndrome (MDS, 17p13.3 deletion syndrome, LIS1-associated lissencephaly) include classic lissencephaly, microcephaly, cardiac malformations, growth restriction, and characteristic facial changes. Individuals with 22q11.2 deletion syndrome (DiGeorge syndrome or velocardiofacial syndrome) are known to have congenital cardiac malformations (in particular conotruncal defects), palatal abnormalities (especially velopharyngeal insufficiency), hypocalcemia, immune deficiency, learning disabilities, and characteristic facial features. This case report describes phenotypic characteristics of a patient with extremely rare instance of having both MDS and 22q11.2 deletion syndrome that is unique in the medical literature. Prognosis in this concurrent phenotype is poor with our patient suffering from several malformations seen in both conditions and expiring in the neonatal period.

Keywords

Miller-Dieker syndrome - 17p13.3 deletion - 22q11.2 deletion syndrome

• References

• 1 Dobyns WB, Das S. LIS1-associated lissencephaly/subcortical band heterotopia. 2009 Mar 3. In: Pagon RA, Adam MP, Ardinger HH, , et al, eds. GeneReviews® [Internet]. Seattle, WA: University of Washington, Seattle; 1993. –2014 http://www.ncbi.nlm.nih.gov/books/NBK5189/ . Accessed March 2015
• 2 McDonald-McGinn DM, Emanuel BS, Zackai EH. 22q11.2 deletion syndrome. 1999 Sep 23 [Updated 2013 Feb 28]. In: Pagon RA, Adam MP, Ardinger HH, , et al, eds. GeneReviews® [Internet]. Seattle, WA: University of Washington, Seattle; 1993. –2014 http://www.ncbi.nlm.nih.gov/books/NBK1523/ . Accessed March 2015
• 3 Bassett AS, McDonald-McGinn DM, Devriendt K , et al; International 22q11.2 Deletion Syndrome Consortium. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr 2011; 159 (2) 332-9.e1
• 4 Schiff M, Delahaye A, Andrieux J , et al. Further delineation of the 17p13.3 microdeletion involving YWHAE but distal to PAFAH1B1: four additional patients. Eur J Med Genet 2010; 53 (5) 303-308
• 5 Bruno DL, Anderlid BM, Lindstrand A , et al. Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes. J Med Genet 2010; 47 (5) 299-311
• 6 Østergaard JR, Graakjær J, Brandt C, Birkebæk NH. Further delineation of 17p13.3 microdeletion involving CRK. The effect of growth hormone treatment. Eur J Med Genet 2012; 55 (1) 22-26
• 7 Prasad SE, Howley S, Murphy KC. Candidate genes and the behavioral phenotype in 22q11.2 deletion syndrome. Dev Disabil Res Rev 2008; 14 (1) 26-34
• 8 Scambler PJ. 22q11 deletion syndrome: a role for TBX1 in pharyngeal and cardiovascular development. Pediatr Cardiol 2010; 31 (3) 378-390
• 9 Chen CP, Chang TY, Guo WY , et al. Chromosome 17p13.3 deletion syndrome: aCGH characterization, prenatal findings and diagnosis, and literature review. Gene 2013; 532 (1) 152-159 10.1016/j.gene.2013.09.044
• 10 Ueda H, Sugiura T, Takeshita S , et al. Combination of Miller-Dieker syndrome and VACTERL association causes extremely severe clinical presentation. Eur J Pediatr 2014; 173 (11) 1541-1544